pemoline has been researched along with Phobic Disorders in 1 studies
Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pemoline was given orally in increasing doses ranging from 20 to 80 mg/day." | 1.27 | EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial. ( Barteselli, F; Besana, R; Caresia, L; Guareschi Cazzullo, A; Musetti, L; Pugnetti, L; Scarone, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caresia, L | 1 |
| Pugnetti, L | 1 |
| Besana, R | 1 |
| Barteselli, F | 1 |
| Guareschi Cazzullo, A | 1 |
| Musetti, L | 1 |
| Scarone, S | 1 |
1 other study available for pemoline and Phobic Disorders
| Article | Year |
|---|---|
EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial.
Topics: Adolescent; Adult; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Depressi | 1984 |